MEModjtaba Emadi-Baygi

Modjtaba Emadi-Baygi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Modjtaba Emadi-Baygi has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Parvaneh Nikpour

    Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran

    18 shared publications
  • Wolfgang Arthur Schulz

    Heinrich Heine University Düsseldorf

    6 shared publications
  • Fatemeh Akhoundi

    Shahrekord University

    4 shared publications
  • Hajar Miranzadeh-Mahabadi

    Department of Genetics, School of Basic Sciences, Shahrekord University, Shahrekord, Iran; Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

    4 shared publications
  • Parvaneh Nikpour

    Department of Genetics and Molecular Biology Faculty of Medicine Isfahan University of Medical Sciences Isfahan Iran

    4 shared publications
  • Roya Kelishadi

    Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran

    4 shared publications

Latest Publications

  • Open Access

    From bulk RNA sequencing to spatial transcriptomics: a comparative review of differential gene expression analysis methods

    by Maryam Kalantari-Dehaghi, Neda Ghohabi-Esfahani, Modjtaba Emadi-Baygi

    Transcriptome analysis is essential to dissect the molecular mechanisms underlying phenotypic differences and disease mechanisms. Traditionally, microarray


  • Open Access

    Comprehensive Computational Assessment of SNAI1 and SNAI2 in Gastric Cancer: Linking EMT, Tumor Microenvironment, and Survival Outcomes

    by Maryam Kalantari-Dehaghi, Hasan Rahimi-Tamandegani, Modjtaba Emadi-Baygi

    Background: Gastric cancer is aggressive with poor prognosis due to high invasion and metastasis rates, a hallmark of cancer. The Snail family (SNAI1 and SNAI2) drives EMT, enabling epithelial cells to gain migratory and invasive traits. Methods: We used “limma” package to identify genes with differential expression between high and low levels of SNAI1/SNAI2 in TCGA stomach adenocarcinoma dataset, intersecting these with cancer invasion and metastasis genes obtained from 5 databases. Using Cox regression analysis, we developed a risk score model and created a nomogram incorporating clinical data. The model’s prognostic accuracy was validated with survival and ROC analyses in both TCGA and GEO datasets. Additionally, we performed WGCNA and constructed a ceRNA network to investigate gene interactions, and used CIBERSORT analysis to evaluate immune cell composition in the tumor microenvironment. Results: We developed 5 and 9 risk signatures and nomograms incorporating clinical data. Survival analysis showed high-risk patients had worse overall survival than low-risk patients. WGCNA identified a lightyellow module associated with SNAI1 and SNAI2 expressions, emphasizing extracellular matrix organization. CeRNA network analyses found 6 common hub genes linked to SNAI1 and SNAI2. Immune profiling showed that SNAI1 expression was related to 8 types of immune cells, while SNAI2 was connected to 6, indicating their roles in influencing the tumor microenvironment. Conclusion: This study highlights the significant prognostic impact of SNAI1 and SNAI2 in stomach adenocarcinoma, linking their high expression to poorer survival and aggressive tumor behavior, while also identifying potential therapeutic targets through comprehensive computational analysis.


  • Open Access

    Insights into Breast Cancer Prognosis: A Differential Regulatory Network Approach to Identify Key Transcription Factor Biomarkers

    by Fereshte Akhoundi, Fatemeh Akhoundi, Mina Ranjbarfard, Modjtaba Emadi-Baygi

    Background. Breast cancer (BC) is the most common and aggressive type of cancer in females, and exploring the mechanisms of disease progression is playing a crucial role in the development of potential therapeutics. Recently, systems biology approaches such as network strategies have been successfully applied to reveal the interaction mechanisms between genes. The main objective of the current study was to investigate potential biomarkers for BC patients at different stages by constructing differential regulatory networks (DRNs). Method. In the present study, clinical information and RNA-seq data from patients with BC were obtained from The Cancer Genome Atlas (TCGA). According to the clinical staging information, the gene expression data of TCGA-BRCA was divided into different stages (stages I–IV) and analyzed separately. The differentially co-expressed genes and links (DCGL) package in R was used to identify differentially co-expressed genes (DCGs) and differentially co-expressed links (DCLs) in different stages (I–IV) of BC patients compared to normal samples. A q < 0.25 was considered the cut-off criterion. Besides, differentially-regulated genes (DRGs) and differentially-regulated links (DRLs) were identified by DCGs, DCLs, and TF-to-target knowledge. Stage-specific gene regulatory networks (GRNs) were further analyzed with Cytoscape to explore the core TFs. Afterward, Kaplan-Meier (K-M) analysis was utilized to explore the prognostic value of the core TFs. Cancer-related pathway analysis of candidate hub TF was done through the GSCALite database. Finally, the relationship between candidate transcription factors expression and tumor-infiltrating lymphocytes was analyzed using TCGA-BRCA data and the TIMER database. Results. From DRNs of stages I–IV, 29 unique core TFs were screened. Survival analysis indicated that the expression ofKLF12,FOS, BACH2 EPAS1,PPARA, andMRPL36had significant effects on the survival of breast cancer patients (P < 0.05). Hub genes were responsible for the infiltration levels of immunocytes. Based on the GSCALite database, these six TFs are significantly related to multiple signaling pathways, including RAS/MAPK, EMT, PI3K/AKT, and TSC/mTOR. These pathways play vital roles in oncogenesis, suggesting that these candidate hub TFs may participate in BC progression. Conclusion. Our findings suggest these six TFs might play important roles in the pathogenesis of BC and could be used as therapeutic targets for BC. However, further studies at the molecular level are required to confirm these observations.


  • Development of a coupled modeling for tumor growth, angiogenesis, oxygen delivery, and phenotypic heterogeneity

    by Mahmood Borzouei, Mohammad Mardaani, Modjtaba Emadi-Baygi, Hassan Rabani

    Analysis of the evolution and growth dynamics of tumors is crucial for understanding cancer and the development of individually optimized therapies. During tumor growth, a hypoxic microenvironment around cancer cells caused by excessive non-vascular tumor growth induces tumor angiogenesis that plays a key role in the ensuing tumor growth and its progression into higher stages. Various mathematical simulation models have been introduced to simulate these biologically and physically complex hallmarks of cancer. Here, we developed a hybrid two-dimensional computational model that integrates spatiotemporally different components of the tumor system to investigate both angiogenesis and tumor growth/proliferation. This spatiotemporal evolution is based on partial diffusion equations, the cellular automation method, transition and probabilistic rules, and biological assumptions. The new vascular network provided by angiogenesis affects tumor microenvironmental conditions and drives individual cells to adapt themselves to spatiotemporal conditions. Furthermore, some stochastic rules are involved besides microenvironmental conditions. Overall, the conditions promote some commonly observed cellular states, i.e., proliferative, migrative, quiescent, and cell death, depending on the condition of each cell. Altogether, our results offer a theoretical basis for the biological evidence that regions of the tumor tissue near blood vessels are densely populated by proliferative phenotypic variants, while poorly oxygenated regions are sparsely populated by hypoxic phenotypic variants.


  • Open Access

    Construction of a three-component regulatory network of transcribed ultraconserved regions for the identification of prognostic biomarkers in gastric cancer

    by Anis Khalafiyan, Modjtaba Emadi-Baygi, Markus Wolfien, Ali Salehzadeh-Yazdi, Parvaneh Nikpour

    Although altered expression and functional roles of the transcribed ultraconserved regions (T-UCRs) in the pathophysiology of neoplasms has already been investigated, relevance of the functions for T-UCRs in gastric cancer (GC) is still the subject of inquiry. In the current study, The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD) dataset was used as a resource for the RNA-sequencing data. Differential expression analysis was conducted using DESeq2. Interactions between T-UCRs, miRNAs, and mRNAs were combined into a three-component network. The Survival package was utilized to identify survival-related differentially-expressed T-UCRs (DET-UCRs). Using an in-house cohort of GC tissues, expression of two DET-UCRs was experimentally verified. Thirty-four T-UCRs were dysregulated in TCGA-STAD tumoral samples compared to non-tumoral counterparts. The network was composed of 34 DET-UCRs, 275 miRNAs and 796 mRNAs nodes. Five T-UCRs were significantly correlated with the overall survival. While no expression of uc.232 was observed in our in-house cohort of GC tissues, uc.343 showed an increased expression in gastric tumoral tissues. The constructed three-component regulatory network of T-UCRs in GC presents a comprehensive understanding of the underlying gene expression regulation processes involved in tumor development and can serve as a basis to investigate potential prognostic biomarkers and therapeutic targets. Simple summary Gastric cancer (GC) is one of the most common cancers in the world and is considered as a highly heterogeneous disease based on subtypes and genetic alterations. GC is mostly detected in the advanced stages, hence, identifying diagnostic and prognostic biomarkers is of urgent need. Transcribed ultraconserved regions (T-UCRs) are a type of long non-coding RNAs which are linked to human carcinogenesis. Their mechanisms of action and the factors regulating their expression in cancers are poorly understood. In the current study, by applying a systems biology approach and constructing a regulatory network, we have presented a T-UCR as a potential diagnostic biomarker. Additionally, five T-UCRs with significant correlation with patients’ overall survival were found, which can be potentially used as prognostic biomarkers in future.

  • Open Access

    Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities

    by Modjtaba Emadi-Baygi, Mahsa Ehsanifard, Najmeh Afrashtehpour, Mahnaz Norouzi, Zahra Joz-Abbasalian

    The current global pandemic of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) causing COVID-19, has infected millions of people and continues to pose a threat to many more. Angiotensin-Converting Enzyme 2 (ACE2) is an important player of the Renin-Angiotensin System (RAS) expressed on the surface of the lung, heart, kidney, neurons, and endothelial cells, which mediates SARS-CoV-2 entry into the host cells. The cytokine storms of COVID-19 arise from the large recruitment of immune cells because of the dis-synchronized hyperactive immune system, lead to many abnormalities including hyper-inflammation, endotheliopathy, and hypercoagulability that produce multi-organ dysfunction and increased the risk of arterial and venous thrombosis resulting in more severe illness and mortality. We discuss the aberrated interconnectedness and forthcoming crosstalks between immunity, the endothelium, and coagulation, as well as how sex disparities affect the severity and outcome of COVID-19 and harm men especially. Further, our conceptual framework may help to explain why persistent symptoms, such as reduced physical fitness and fatigue during long COVID, may be rooted in the clotting system.


  • Open Access

    A Metabolic Model of Intestinal Secretions: The Link between Human Microbiota and Colorectal Cancer Progression

    by Pejman Salahshouri, Modjtaba Emadi-Baygi, Mahdi Jalili, Faiz M. Khan, Olaf Wolkenhauer, Ali Salehzadeh-Yazdi

    The human gut microbiota plays a dual key role in maintaining human health or inducing disorders, for example, obesity, type 2 diabetes, and cancers such as colorectal cancer (CRC). High-throughput data analysis, such as metagenomics and metabolomics, have shown the diverse effects of alterations in dynamic bacterial populations on the initiation and progression of colorectal cancer. However, it is well established that microbiome and human cells constantly influence each other, so it is not appropriate to study them independently. Genome-scale metabolic modeling is a well-established mathematical framework that describes the dynamic behavior of these two axes at the system level. In this study, we created community microbiome models of three conditions during colorectal cancer progression, including carcinoma, adenoma and health status, and showed how changes in the microbial population influence intestinal secretions. Conclusively, our findings showed that alterations in the gut microbiome might provoke mutations and transform adenomas into carcinomas. These alterations include the secretion of mutagenic metabolites such as H2S, NO compounds, spermidine and TMA (trimethylamine), as well as the reduction of butyrate. Furthermore, we found that the colorectal cancer microbiome can promote inflammation, cancer progression (e.g., angiogenesis) and cancer prevention (e.g., apoptosis) by increasing and decreasing certain metabolites such as histamine, glutamine and pyruvate. Thus, modulating the gut microbiome could be a promising strategy for the prevention and treatment of CRC.


  • Open Access

    Predicting the most deleterious missense nsSNPs of the protein isoforms of the human HLA-G gene and in silico evaluation of their structural and functional consequences

    by Elaheh Emadi, Fatemeh Akhoundi, Seyed Mehdi Kalantar, Modjtaba Emadi-Baygi

    Background: The Human Leukocyte Antigen G (HLA-G) protein is an immune tolerogenic molecule with 7 isoforms. The change of expression level and some polymorphisms of the HLA-G gene are involved in various pathologies. Therefore, this study aimed to predict the most deleterious missense non-synonymous single nucleotide polymorphisms (nsSNPs) in HLA-G isoforms via in silico analyses and to examine structural and functional effects of the predicted nsSNPs on HLA-G isoforms. Results: Out of 301 reported SNPs in dbSNP, 35 missense SNPs in isoform 1, 35 missense SNPs in isoform 5, 8 missense SNPs in all membrane-bound HLA-G isoforms and 8 missense SNPs in all soluble HLA-G isoforms were predicted as deleterious by all eight servers (SIFT, PROVEAN, PolyPhen-2, I-Mutant 3.0, SNPs&GO, PhD-SNP, SNAP2, and MUpro). The Structural and functional effects of the predicted nsSNPs on HLA-G isoforms were determined by MutPred2 and HOPE servers, respectively. Consurf analyses showed that the majority of the predicted nsSNPs occur in conserved sites. I-TASSER and Chimera were used for modeling of the predicted nsSNPs. rs182801644 and rs771111444 were related to creating functional patterns in 5′UTR. 5 SNPs in 3′UTR of the HLA-G gene were predicted to affect the miRNA target sites. Kaplan-Meier analysis showed the HLA-G deregulation can serve as a prognostic marker for some cancers. Conclusions: The implementation of in silico SNP prioritization methods provides a great framework for the recognition of functional SNPs. The results obtained from the current study would be called laboratory investigations.


  • Open Access

    Identification of a novel HEXB Mutation in an Iranian Family with suspected patient to GM2‐gangliosidoses

    by Fatemeh Mansouri‐Movahed, Fatemeh Akhoundi, Parvaneh Nikpour, Masoud Garshasbi, Modjtaba Emadi‐Baygi

    Sandhoff disease is one of the GM2‐gangliosidoses which is caused by a mutation in the HEXB preventing the breakdown of GM2‐ganglioside. We report a novel HEXB variant in a family with a history of a dead girl with Sandhoff disease which was not found in controls.


  • Open Access

    Synthetic Biology Based on Genetic Logic Circuit, Using the Expression of Drug Resistance, BCRP Pump in MCF-7 Cancer Cell Line

    by Marzieh Gerami, Modjtaba Emadi-Baygi, Mohammad Eshghi, Fatemeh Elahian, Razieh Heidari, Mehdi Hosseinzadeh

    Biological circuits are developed as biological parts within a cell to carry out logical functions resembling those studied in electronics circuits. These circuits can be performed as a method to vary cellular functions, to develop cellular responses to environmental conditions, or to regulate cellular developments. This research explored the possibility of synthetic biology based on the genetic logic circuit A and (not B) using the inducible expression of the both BCRP drug resistance pump and its specific shRNA in MCF-7 cancer cell line utilizing the third generation of lentiviral vectors. The accuracy of the output of the proposed circuit for living cells, was confirmed by the results of the Real-Time PCR and flow cytometry at the RNA and protein levels. At the RNA level, the effect of the inducers on the BCRP gene expression and silencing were investigated by real-time PCR. Furthermore, at the protein level, induction of the expression of the BCRP pump resulted in driving out of the substrate from inside the cells leading to the decrease of the fluorescent emission from the transfected cells. We successfully designed and implemented the genetic logic circuit A and (not B) using the inducible expression of the both BCRP drug resistance pump and its specific shRNA in MCF-7 cancer cells.